Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismCardiovascular disease in HIV patients: from bench to bedside and backwards.Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavir.Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient.A review of nelfinavir for the treatment of HIV infection.Simvastatin: present and future perspectives.HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice.The Relationship Between HIV Infection and Cardiovascular Disease.Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.Drug interactions with statins.Coronary artery disease in patients with HIV infection.A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine ProductsAcute coronary syndromes in patients with HIV.Evidence-based review of statin use in patients with HIV on antiretroviral therapy.Simvastatin co-prescribed with protease inhibitors despite dangerous drug interactions.Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
P2860
Q24603957-C4C7BB3B-AA19-457B-8228-894969D0DDE9Q35203971-2021D72D-34C2-431C-83FF-2C00BF4BBF77Q35501523-65DFB085-78FB-4A44-ACB5-326E386332DDQ35567828-34D196C6-F13F-4A17-96B7-571067613FD0Q35573656-C13A96C2-405B-47A8-9F1B-E2DF82C00EECQ36546278-C27FD26E-475E-4F25-94DD-FCC0583D9F57Q36916934-BEE39483-D9E7-47E8-A1FB-C6B8C08FCE81Q36956654-AC04CB17-EF04-499B-BE47-0CB4E8B57977Q37339362-7788670C-8BA2-488C-8B52-818053E14437Q37429096-24239071-CA9E-4D96-9EAD-CF47D5354C9AQ38109095-72B3FF3C-1A3A-464C-8B02-9113AFC400D3Q38155016-C2B2F6A7-4FDD-4D3F-A4BB-4CC579CF5F69Q38352065-628A96BD-27CA-486A-A2E1-13988347D876Q38513275-B310BD0D-015B-4BDA-9814-20C7B5E0FBD2Q39009201-4169F94B-F4C9-460F-A944-4491FF6F66FCQ42656331-D5551B33-5927-4452-9E67-84DC3D10F880Q43231793-1AB58AC8-0D02-4661-B8A1-C11E13AB071CQ46758177-9E06D549-46AF-45EA-8E0F-D1FE566F0E8FQ51082870-E7F69D62-FE13-4913-A6FD-FED10CEC57AFQ58290838-BF7A6F4B-6CB1-40B2-9993-740E22962E31
P2860
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@en
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@nl
type
label
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@en
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@nl
prefLabel
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@en
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@nl
P2093
P2860
P356
P1476
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
@en
P2093
C Bradley Hare
Carl Grunfeld
Harry W Lampiris
P2860
P304
P356
10.1086/344179
P407
P577
2002-10-25T00:00:00Z